Glenmark Therapeutics takes on Pataday with new OTC eye solution—what you need to know

Glenmark Therapeutics Inc., USA, has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), marking a significant development in the over-the-counter eye care market. This new ... Read More